{
  "pmcid": "10994242",
  "sha256": "3813056635b5e0833ce8dec07d5ff7ecc6bbe3a8d3c268ad23df7272dcf4b897",
  "timestamp_utc": "2025-11-09T23:11:15.553182+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.514127324749648,
    "reading_ease": 21.22857773009062,
    "word_count": 233
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of ANP-HA-GNPs for Chemoresistant Retinoblastoma"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised controlled trial was conducted using an in ovo chicken chorioallantoic membrane model and an orthotopic in vivo RB rat eye model."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Etoposide-resistant RB cells were treated with ANP-HA-GNPs, with phosphate-buffered saline (PBS) serving as the control."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the potential of atrial natriuretic peptide-conjugated hyaluronic acid-coated gold nanoparticles (ANP-HA-GNPs) as an adjuvant treatment for chemoresistant RB."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was tumor growth reduction, assessed over a 7-day period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence, and allocation was concealed with sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to treatment allocation."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 60 eggs were randomised: 30 to the ANP-HA-GNPs group and 30 to the control group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "ANP-HA-GNPs significantly reduced tumor growth and angiogenesis compared to controls (mean difference = 2.5 mm, 95% CI 1.8 to 3.2; p < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group, indicating a favorable safety profile."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not provided."
      },
      "Funding": {
        "score": 1,
        "evidence": "The study was supported by institutional grants."
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}